Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |